The 11-year long-term follow-up study from the randomized BENEFIT CIS trial

OBJECTIVE: To assess outcomes for patients treated with interferon beta-1b immediately after clinically isolated syndrome (CIS) or after a short delay. METHODS: Participants in BENEFIT (Betaferon/Betaseron in Newly Emerging MS for Initial Treatment) were randomly assigned to receive interferon beta-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Neurology
Main Authors: Kappos, Ludwig, Edan, Gilles, Freedman, Mark S., Montalbán, Xavier, Hartung, Hans-Peter, Hemmer, Bernhard, Fox, Edward J., Barkhof, Frederik, Schippling, Sven, Schulze, Andrea, Pleimes, Dirk, Pohl, Christoph, Sandbrink, Rupert, Suarez, Gustavo, Wicklein, Eva-Maria
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5027814/
https://ncbi.nlm.nih.gov/pubmed/27511182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003078
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki